Lamotrigine in the Treatment of Bipolar Disorder in Women of Reproductive Age
Completed
Conditions studied: Bipolar Disorder
In brief
This project will expand current knowledge of reproductive biology in women with bipolar disorder as well as assessing the impact of lamotrigine use for the treatment of bipolar disorder on reproductive function. Specifically, this study examines mood over the menstrual cycle and ovulation for three consecutive menstrual cycles in women treated for bipolar I, II, or NOS (not otherwise specified) with lamotrigine. In addition, testosterone and lipid concentrations will be measured before the participant starts receiving lamotrigine, as well as six months after receiving lamotrigine.
Key facts
- Study ID
- NCT00238576
- Run by
- Stanford University
- People needed
- 30
- Starts
- 2008-05-01
- Expected to finish
- 2012-05-01
- Last updated by the study team
- 2016-04-21
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine — Stanford, California, United States
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.